Kind Pharmaceuticals Llc

This study is testing a new drug called AND017 to see if it can safely and effectively manage anemia (low red blood cells) in people with end-stage kidney disease who require dialysis. It will compare AND017 to an existing standard treatment over about a year. The main goal is to…

This study is testing an investigational oral drug called AND017 for people with lower-risk myelodysplastic syndromes (MDS) who have anemia. The main goal is to see if the drug can safely increase hemoglobin levels (a measure of red blood cells) and reduce the need for blood tran…

This is the first study in people to test a new oral drug called AND019. It aims to find a safe dose and see early signs of whether it can help control advanced breast cancer that has stopped responding to standard hormone therapies. The study will enroll about 61 postmenopausal …

This study is testing a new drug called AND017 to see if it can safely and effectively manage anemia in people with chronic kidney disease who are not on dialysis. It will compare AND017 to an existing treatment to see which one does a better job of keeping patients' red blood ce…

This study is testing whether an oral medication called AND017 can help people with β-thalassemia. Researchers want to see if it safely reduces the need for blood transfusions in those who require them regularly, and increases hemoglobin levels in those who don't. The trial invol…